8-K: INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update

INmune Bio Inc. will host a conference call on May 8, 2025, to discuss its first quarter 2025 financial results and provide a corporate update.

Summary

• INmune Bio Inc. will host a conference call on Thursday, May 8, 2025, at 4:30 p.m. Eastern Time to discuss its first quarter results for the period ended March 31, 2025.
• The company will also provide a corporate update during the call.
• A live audio webcast will be available, and a transcript will be provided approximately 24 hours after the call.
• A replay will be available through May 22nd, 2025.

Sentiment

Score: 5

Explanation: The document is neutral, simply announcing an upcoming conference call. There is no explicit positive or negative sentiment expressed.

Risks

• The press release contains forward-looking statements that are subject to risks and uncertainties.
• Clinical trials for INB03, XPro1595, and INKmune are in early stages, and there is no assurance of FDA approval or specific results.
• The company's ability to continue operations depends on securing additional funding.
• The company's business, research, product development, regulatory approval, marketing and distribution plans and strategies are subject to risks and uncertainties.

Future Outlook

The company will provide a corporate update during the conference call, but no specific forward-looking guidance is included in the press release.

Industry Context

INmune Bio is a clinical-stage biotechnology company focused on developing treatments targeting the innate immune system to fight diseases, particularly those driven by chronic inflammation and cancer, placing it within the competitive landscape of companies developing immunotherapies and treatments for neurodegenerative diseases like Alzheimer's.

Stakeholder Impact

• Shareholders will receive an update on the company's financial performance and corporate activities.
• Investors can participate in the conference call or access the webcast and replay to learn more about the company's progress.

Next Steps

• INmune Bio will host a conference call on May 8, 2025, to discuss its first quarter 2025 financial results and provide a corporate update.

Key Dates

Keywords

INmune Bio, Financial Results, Corporate Update, Conference Call, Biotechnology, Inflammation, Immunology, Alzheimers Disease, Microglial Activation, Neuroinflammation, DN-TNF, NK Cells, CORDStrom